Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

7 results

Filter Results By

Filter Applied. Clear All

Latest Posts

March 25, 2024 Filed: CLI Amicus Brief in Idaho’s Moyle v. United States EMTALA Case Filed: CLI Amicus Brief in Idaho’s Moyle v. United States EMTALA Case March 22, 2024 Fact Sheet: Three Problems with the FDA’s Abortion Drugs Complications Data Fact Sheet: Three Problems with the FDA’s Abortion Drugs Complications Data March 21, 2024 Filed: CLI Amicus Brief in SCOTUS Case FDA v. Alliance for Hippocratic Medicine Filed: CLI Amicus Brief in SCOTUS Case FDA v. Alliance for Hippocratic Medicine
Reset All Filters
7 results
featured-image

Bicameral Congressional Letter Demands Transparency from FDA

Yesterday 75 members of Congress, led by Rep. Chris Smith of New Jersey and Sen. James Lankford of Oklahoma, sent a letter to the Commissioner of the Food and Drug Administration demanding answers to questions about the FDA’s surprise approval of relaxed protocols for the distribution of the abortion-inducing drug regimen known as Mifeprex.

Charles A. “Chuck” Donovan
April 26, 2016
ClosePlease login

New CLI Scholar to Testify at “Pricing of Fetal Tissue” Congressional Hearing

Testimony of CLI Assoc. Scholar in Support of the Prenatal Nondiscrimination Act

On April 14, the House Judiciary Committee held a hearing on HR 4924, the Prenatal Nondiscrimination Act (PRENDA) of 2016, sponsored by Rep. Trent Franks. The bill would prohibit discrimination against the unborn based on the preference of sex or race alone. Charlotte Lozier Institute associate scholar Anna Higgins, J.D. testified in support of the bill, and summarized her newly published paper on sex-selection abortion.

featured-image

Fox Foundation Funding Patterns Favor Ethical Approaches

But while the Fox Foundation, like CIRM, may have started out emphasizing support for hESCR, that support, also like CIRM’s, has waned over the years. According to its website, the MJFF has awarded 1,350 research grants since its founding in 2000.  Of that total number, just 66 grants went to research using stem cells.

Sex-Selection Abortion: The Real War on Women

Despite advances in civil rights and the recognition by most developed nations that discrimination on the basis of sex alone is inherently unjust, a very real and pervasive form of sex discrimination is still permitted and practiced in the world today. Prenatal sex discrimination crosses cultural, ethnic, and national lines. It is practiced with impunity in many countries, including the U.S., via sex-selective abortion – choosing to abort a preborn child based solely on the child’s sex. Prenatal discrimination can also be practiced pre-implantation by destroying embryos based on a pre-implantation sex determination.  Undoubtedly, such practices constitute discrimination against a unique human individual based on sex alone, and thus constitute sex discrimination. In order to address this injustice, it is imperative that States and the Federal Government institute selection abortion bans – restrictions on abortions done for reasons of sex selection alone.

Medication Abortion: FDA Guidelines and Personal Experience

Last week, the Food and Drug Administration (FDA) changed the regulations for RU-486, the “abortion pill,” allowing its use up to 70 days into pregnancy, three weeks past the previous guidelines. On the same day, Abby Johnson’s The Walls Are Talking: Former Abortion Clinic Workers Tell Their Stories, was officially released. One chapter in particular stood out as especially timely in regards to the news: “Medication Abortion.”

Minnesota Reports Show Smaller Abortion Centers Shrinking as Planned Parenthood Consolidates into Mega-Clinics

The Minnesota Department of Health publishes an extensive and organized annual abortion report that presents important public health information, including demographic statistics, while protecting the anonymity of women. Additionally, Minnesota reports the volume of abortions performed at each facility in the state. Minnesota’s abortion trends provide a glimpse of what is happening to the abortion market on a national scale. Similar to national trends, the total number of abortions in Minnesota has decreased, one abortion facility has closed, several have merged, and Planned Parenthood increasingly dominates the market.

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image